• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Disease Management: Better care, but not much savings

Article

Disease management programs generally do right by patients, but there's no evidence that they save money over the long term, according to a new study from the RAND Corporation.

Disease management programs generally do right by patients, but there's no evidence that they save money over the long term, according to a new study from the RAND Corporation. "People take for granted that these programs work and save money, because the concept is very plausible," says Soeren Mattke, the report's lead author.

The study looked at various disease management programs and their effect on six chronic conditions: congestive heart failure, coronary artery disease, diabetes, asthma, depression, and chronic obstructive pulmonary disease. Despite the paucity of evidence related to savings, disease management programs improved patients' health for four out of six conditions, even though most of the studies reviewed by Mattke and his colleagues followed patients only for about a year. (Data on asthma and COPD were inconclusive.)

Related Videos